Clinical Significance of Programmed Death-1 Ligand-1 Expression in Patients with Non-Small Cell Lung Cancer: A 5-year-follow-up Study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Significance of Programmed Death-1 Ligand-1 Expression in Patients with Non-Small Cell Lung Cancer: A 5-year-follow-up Study
Authors
Keywords
-
Journal
TUMORI
Volume 98, Issue 6, Pages 751-755
Publisher
SAGE Publications
Online
2018-02-27
DOI
10.1177/030089161209800612
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor progression by immune evasion in melanoma
- (2010) Mohammed Kashani-Sabet CANCER
- Clinical significance of B7-H1（PD-L1）expression in human acute leukemia
- (2010) Xiangli Chen et al. CANCER BIOLOGY & THERAPY
- Cancer Trends in China
- (2010) P. Zhao et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
- (2010) Chuan-Yong Mu et al. MEDICAL ONCOLOGY
- B7-H1 Expression in Vestibular Schwannomas
- (2010) David J. Archibald et al. OTOLOGY & NEUROTOLOGY
- Clinical Significance of B7-H1 and B7-1 Expressions in Pancreatic Carcinoma
- (2010) Liancai Wang et al. WORLD JOURNAL OF SURGERY
- The New Lung Cancer Staging System
- (2009) Frank C. Detterbeck et al. CHEST
- Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
- (2009) Q. Gao et al. CLINICAL CANCER RESEARCH
- 7th Revision of the Declaration of Helsinki: Good News for the Transparency of Clinical Trials
- (2009) Karmela Krleža-Jerić et al. CROATIAN MEDICAL JOURNAL
- New TNM classification for non-small-cell lung cancer
- (2009) Lynn T Tanoue et al. Expert Review of Anticancer Therapy
- Cancer immunoediting and “spontaneous” tumor regression
- (2009) Neel Sengupta et al. PATHOLOGY RESEARCH AND PRACTICE
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
- (2008) T. Azuma et al. BLOOD
- B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression
- (2008) Lei Geng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- B7-H1 Expression in Wilms Tumor: Correlation With Tumor Biology and Disease Recurrence
- (2008) Jonathan C. Routh et al. JOURNAL OF UROLOGY
- Diagnostic and Prognostic Molecular Markers in Renal Cell Carcinoma
- (2008) Hari S.G.R. Tunuguntla et al. JOURNAL OF UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now